Moderna, Inc. (NASDAQ:MRNA – Get Free Report) Director Noubar Afeyan sold 15,000 shares of the business’s stock in a transaction dated Wednesday, June 5th. The stock was sold at an average price of $151.25, for a total value of $2,268,750.00. Following the transaction, the director now directly owns 1,946,931 shares of the company’s stock, valued […]

Related Keywords

United States , Noubar Afeyan , Principle Wealth Partners , Moderna Inc , Nasdaq , Securities Exchange Commission , Income Strategies , Canaccord Genuity Group , Moderna Company Profile , Cedar Wealth Management , National Association , Get Free Report , Director Noubar Afeyan , Exchange Commission , Genuity Group , Wealth Management , Wealth Partners , Sound Income Strategies , Moderna Daily ,